Dennis Karl Huang - 01 Mar 2023 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
EVP, Chief Technical Operations Officer
Signature
/s/ Karah Parschauer, attorney-in-fact
Issuer symbol
RARE
Transactions as of
01 Mar 2023
Net transactions value
-$501,602
Form type
4
Filing time
03 Mar 2023, 18:53:55 UTC
Previous filing
03 Mar 2022
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Award $0 +2,663 +5.2% $0.000000 53,703 01 Mar 2023 Direct F1
transaction RARE Common Stock Award $0 +22,000 +41% $0.000000 75,703 01 Mar 2023 Direct F2
transaction RARE Common Stock Sale $17,758 -389 -0.51% $45.65 75,314 01 Mar 2023 Direct F3
transaction RARE Common Stock Disposed to Issuer $483,844 -10,599 -14% $45.65 64,715 01 Mar 2023 Direct F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RARE Stock Option (Right to Buy) Award $0 +39,400 $0.000000 39,400 01 Mar 2023 Common Stock 39,400 $45.65 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric.
F2 Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.
F3 Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
F4 Shares were acquired upon the partial vesting of a previously reported RSU and were sold to permit the cash value of the awards to be credited to the deferred compensation plan account of the Reporting Person.
F5 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
F6 On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Remarks:

EVP, Chief Technical Operations Officer